SNODGRASS H. RALPH 4
4 · VistaGen Therapeutics, Inc. · Filed Jan 4, 2021
Insider Transaction Report
Form 4
SNODGRASS H. RALPH
DirectorPRES./CHIEF SCIENTIFIC OFFICER
Transactions
- Award
Stock Option (Right to Buy)
2020-12-30+150,000→ 150,000 totalExercise: $1.77Exp: 2030-12-30→ Common Stock (150,000 underlying) - Award
Common Stock
2020-12-31$0.45/sh+5,000$2,261→ 87,724 total
Footnotes (2)
- [F1]Shares purchased under the Vistagen Therapeutics, Inc. 2019 Employee Stock Purchase Plan on December 31, 2020 in a transaction exempt under Rule 16b-3(c).
- [F2]Twenty-five percent (25%) of the total number of shares shall be vested immediately on December 31, 2020 (the "Vesting Start Date") and 1/24th of the remaining number of shares shall vest monthly thereafter until all awarded shares are fully vested two (2) years after the Vesting Start Date.